Valuation (38%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 27.02 | 12.57 |
| PEG Ratio (TTM) | -1.43 | 0.42 |
| P/S Ratio (TTM) | 1.65 | 1.79 |
| P/B Ratio (TTM) | 1.13 | 9.71 |
| P/FCF Ratio (TTM) | 17.62 | 18.80 |
| Price to 5YR AVG Earnings Ratio | -41.65 | -8.40 |
| Price to 5YR AVG FCF Ratio | -59.26 | 68.26 |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.11% | 2.48% |
| ROE (TTM) | 4.18% | 9.85% |
| Net Profit Margin (TTM) | 6.21% | 2.00% |
| ROIC 5YR AVG | -1.19% | 1.48% |
Growth (52%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 14.08% | -50.23% | -4.60% |
| Revenue | 2.04% | 9.97% | 22.76% |
| Net Income | 23.44% | -52.05% | -4.25% |
| Cash Flow | 9.40% | -19.31% | 1,799.40% |
Health (44%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.09 | 1.18 |
| Quick Ratio (TTM) | 1.09 | 0.36 |
| D/E Ratio (TTM) | 0.71 | 1.44 |
| Interest Coverage (TTM) | -0.75 | 0.91 |
| Piotroski F-Score | 9 | 7 |
| Altman Z-Score | 0.90 | 1.09 |
| LTL to 5YR AVG FCF | -42.00 | 19.34 |
| Shares Outstanding Growth 5YR AVG | 0.61% | 4.39% |